218 related articles for article (PubMed ID: 25910330)
21. M-M-R(®)II manufactured using recombinant human albumin (rHA) and M-M-R(®)II manufactured using human serum albumin (HSA) exhibit similar safety and immunogenicity profiles when administered as a 2-dose regimen to healthy children.
Wiedmann RT; Reisinger KS; Hartzel J; Malacaman E; Senders SD; Giacoletti KE; Shaw E; Kuter BJ; Schödel F; Musey LK
Vaccine; 2015 Apr; 33(18):2132-40. PubMed ID: 25796337
[TBL] [Abstract][Full Text] [Related]
22. Antibody responses to routine pediatric vaccines administered with 13-valent pneumococcal conjugate vaccine.
Bryant KA; Gurtman A; Girgenti D; Reisinger K; Johnson A; Pride MW; Patterson S; Devlin C; Gruber WC; Emini EA; Scott DA
Pediatr Infect Dis J; 2013 Apr; 32(4):383-8. PubMed ID: 23104129
[TBL] [Abstract][Full Text] [Related]
23. EPI vaccines-induced antibody prevalence in 8-9 year-olds in The Gambia.
Viviani S; Mendy M; Jack AD; Hall AJ; Montesano R; Whittle HC
Trop Med Int Health; 2004 Oct; 9(10):1044-9. PubMed ID: 15482396
[TBL] [Abstract][Full Text] [Related]
24. Recommended childhood immunization schedule--United States, 1997.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1997 Jan; 46(2):35-40. PubMed ID: 9011782
[TBL] [Abstract][Full Text] [Related]
25. [The level of postvaccinal immunity to diphtheria, tetanus and poliomyelitis in relation to the number of inoculations].
Chudnaia LM; Oksiiuk VG; Shekhter AB; Krasiuk LS; Afanas'eva SM; Bryzhata SI; Kozhan NE; Chaban EP
Zh Mikrobiol Epidemiol Immunobiol; 1991 Jan; (1):46-9. PubMed ID: 1650072
[TBL] [Abstract][Full Text] [Related]
26. [A serological survey on antibodies to polio, measles, diphtheria and tetanus in Yichang human population].
He H
Zhonghua Liu Xing Bing Xue Za Zhi; 1993 Apr; 14(2):96-8. PubMed ID: 8394775
[TBL] [Abstract][Full Text] [Related]
27. Response to measles, mumps and rubella vaccine in paediatric bone marrow transplant recipients.
King SM; Saunders EF; Petric M; Gold R
Bone Marrow Transplant; 1996 Apr; 17(4):633-6. PubMed ID: 8722367
[TBL] [Abstract][Full Text] [Related]
28. Antibody levels to diphtheria, tetanus, and rubella in infants vaccinated while on PD: a Study of the Pediatric Peritoneal Dialysis Study Consortium.
Neu AM; Warady BA; Furth SL; Lederman HM; Fivush BA
Adv Perit Dial; 1997; 13():297-9. PubMed ID: 9440877
[TBL] [Abstract][Full Text] [Related]
29. Multimodal safety assessment of measles-mumps-rubella vaccination after pediatric liver transplantation.
Pittet LF; Verolet CM; McLin VA; Wildhaber BE; Rodriguez M; Cherpillod P; Kaiser L; Siegrist CA; Posfay-Barbe KM
Am J Transplant; 2019 Mar; 19(3):844-854. PubMed ID: 30171797
[TBL] [Abstract][Full Text] [Related]
30. Simultaneous administration of diphtheria/tetanus/pertussis/polio vaccine and hepatitis B vaccine in a simplified immunization programme.
Coursaget P; Yvonnet B; Relyveld EH; Barres JL; Diop-Mar I; Chiron JP
Dev Biol Stand; 1986; 65():169-75. PubMed ID: 2881821
[TBL] [Abstract][Full Text] [Related]
31. Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional study.
Heijstek MW; van Gageldonk PG; Berbers GA; Wulffraat NM
Ann Rheum Dis; 2012 Jun; 71(6):948-54. PubMed ID: 22172491
[TBL] [Abstract][Full Text] [Related]
32. Vaccination status of children considered for renal transplants: missed opportunities for vaccine preventable diseases.
Genc G; Ozkaya O; Aygun C; Yakupoglu YK; Nalcacioglu H
Exp Clin Transplant; 2012 Aug; 10(4):314-8. PubMed ID: 22845763
[TBL] [Abstract][Full Text] [Related]
33. [The efficacy of the ADTP-vaccine immunization of children with different courses of the vaccinal period].
Sliusar' LI; Romanenko TA; Dubil'er Zhi ; Panasenko LI; Litvinova TP
Pediatriia; 1992; (10-12):22-5. PubMed ID: 1291954
[No Abstract] [Full Text] [Related]
34. Long-term antibody persistence after booster vaccination with combined tetravalent diphtheria tetanus, whole-cell Bordetella pertussis and hepatitis B vaccine in healthy infants.
Poovorawan Y; Theamboonlers A; Sanpavat S; Chumdermpadetsuk S; Safary A; Vandepapeliere P
Ann Trop Paediatr; 1997 Dec; 17(4):301-8. PubMed ID: 9578788
[TBL] [Abstract][Full Text] [Related]
35. Vaccines and immunization schedules.
Nagel J
Trop Geogr Med; 1985 Sep; 37(3):S42-9. PubMed ID: 2866613
[TBL] [Abstract][Full Text] [Related]
36. Routine vaccines across the life span, 2003.
Zimmerman RK; Middleton DB; Burns IT; Clover RD
J Fam Pract; 2003 Jan; 52(1 Suppl):S1-21. PubMed ID: 12556275
[TBL] [Abstract][Full Text] [Related]
37. The recommended childhood immunization schedule of the United States. Committee on Infectious Diseases, American Academy of Pediatrics and Center for Disease Control.
Hall CB
Pediatrics; 1995 Jan; 95(1):135-7. PubMed ID: 7770292
[No Abstract] [Full Text] [Related]
38. Antibody persistence after a primary series of a new DTaP-IPV-Hep B-PRP-T combined vaccine or separate DTaP-IPV//PRP-T and hepatitis B vaccines at 2, 4, and 6 months of age and the effect of a subsequent DTaP-IPV//PRP-T booster vaccination at 18 months of age in healthy Argentinean infants.
Tregnaghi M; Zambrano B; Santos-Lima E
Pediatr Infect Dis J; 2012 Jan; 31(1):e24-30. PubMed ID: 22157567
[TBL] [Abstract][Full Text] [Related]
39. [Responses to triple viral and tetanus vaccination in HIV-infected children].
Echeverría Lecuona J; Aldamiz-Echevarría Azuara L; Cilla Eguiluz G; Pérez Trallero E
An Esp Pediatr; 1996 Apr; 44(4):317-20. PubMed ID: 8849078
[TBL] [Abstract][Full Text] [Related]
40. Measles-mumps-rubella revaccination; 18 months vs. 4-6 years of age: potential impacts of schedule changes.
Saffar MJ; Fathpour GR; Parsaei MR; Ajami A; Khalilian AR; Shojaei J; Saffar H
J Trop Pediatr; 2011 Oct; 57(5):347-51. PubMed ID: 21078605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
